Search - tctmd.com

Displaying 21 - 40 of 86

Sort: Relevancy | Date

Presentation TCT 2023

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis

Presenter: Franz Kleber

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 611: Clinical Outcomes after First Episode In-Stent Restenosis (ISR) Percutaneous Coronary Intervention: Diabetics Versus Non-Diabetics

Presenter: Amit Hooda

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Conference News ISET 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Caitlin E. Cox

January 25, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Daily News

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Michael O'Riordan

September 27, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Conference News SCAI 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

L.A. McKeown

May 22, 2022

Advertisement

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 611: Clinical Outcomes after First Episode In-Stent Restenosis (ISR) Percutaneous Coronary Intervention: Diabetics Versus Non-Diabetics

What’s Going to Be Hot at TCT 2023

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Risk of Radiation Low for Pregnant Operators When Precautions Taken

FLASH: More Data to Support Mechanical Thrombectomy in PE

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

High Lp(a) May Predict Risk of CV and Limb Events in PAD

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content